Suppr超能文献

微小RNA-125b通过靶向细胞周期抑制剂p19来调节巨核细胞成熟。

miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19.

作者信息

Qu Mingyi, Fang Fang, Zou Xiaojing, Zeng Quan, Fan Zeng, Chen Lin, Yue Wen, Xie Xiaoyan, Pei Xuetao

机构信息

Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, Beijing 100850, China.

South China Research Center for Stem Cell and Regenerative Medicine, South China Institute Biomedicine, Guangzhou 510005, China.

出版信息

Cell Death Dis. 2016 Oct 20;7(10):e2430. doi: 10.1038/cddis.2016.288.

Abstract

A better understanding of the mechanisms involved in megakaryocyte maturation will facilitate the generation of platelets in vitro and their clinical applications. A microRNA, miR-125b, has been suggested to have important roles in the self-renewal of megakaryocyte-erythroid progenitors and in platelet generation. However, miR-125b is also critical for hematopoietic stem cell self-renewal. Thus, the function of miR-125b and the complex signaling pathways regulating megakaryopoiesis remain to be elucidated. In this study, an attentive examination of the endogenous expression of miR-125b during megakaryocyte differentiation was performed. Accordingly, the differentiation of hematopoietic stem cells requires the downregulation of miR-125b, whereas megakaryocyte determination and maturation synchronize with miR-125b accumulation. The overexpression of miR-125b improves megakaryocytic differentiation of K562 and UT-7 cells. Furthermore, stage-specific overexpression of miR-125b in primary cells demonstrates that miR-125b mediates an enhancement of megakaryocytic differentiation after megakaryocyte determination, the stage at which megakaryocytes are negative for the expression of the hematopoietic progenitor marker CD34. The identification of miR-125b targets during megakaryopoiesis was focused on negative regulators of cell cycle because the transition of the G1/S phase has been associated with megakaryocyte polyploidization. Real-time PCR, western blot and luciferase reporter assay reveal that p19 is a direct target of miR-125b. P19 knockdown using small interfering RNA (siRNA) in megakaryocyte-induced K562 cells, UT-7 cells and CD61 promegakaryocytes results in S-phase progression and increased polyploidy, as well as improved megakaryocyte differentiation, similarly to the effects of miR-125b overexpression. P19 overexpression reverses these effects, as indicated by reduced expression of megakaryocyte markers, G1-phase arrest and polyploidy decrease. P19 knockdown in miR-125b downregulated cells or p19 overexpression in miR-125b upregulated cells rescued the effect of miR-125b. Taken together, these findings suggest that miR-125b expression positively regulates megakaryocyte development since the initial phases of megakaryocyte determination, and p19 is one of the key mediators of miR-125b activity during the onset of megakaryocyte polyploidization.

摘要

更好地理解巨核细胞成熟所涉及的机制将有助于体外血小板的生成及其临床应用。一种微小RNA,即miR-125b,已被认为在巨核细胞-红系祖细胞的自我更新以及血小板生成中发挥重要作用。然而,miR-125b对造血干细胞的自我更新也至关重要。因此,miR-125b的功能以及调节巨核细胞生成的复杂信号通路仍有待阐明。在本研究中,我们对巨核细胞分化过程中miR-125b的内源性表达进行了仔细检测。相应地,造血干细胞的分化需要miR-125b的下调,而巨核细胞的确定和成熟与miR-125b的积累同步。miR-125b的过表达可改善K562和UT-7细胞的巨核细胞分化。此外,在原代细胞中阶段特异性过表达miR-125b表明,miR-125b在巨核细胞确定后介导巨核细胞分化增强,此时巨核细胞对造血祖细胞标志物CD34的表达呈阴性。由于G1/S期的转变与巨核细胞多倍体化相关,因此在巨核细胞生成过程中对miR-125b靶标的鉴定集中在细胞周期的负调节因子上。实时PCR、蛋白质印迹和荧光素酶报告基因检测表明p19是miR-125b的直接靶标。在巨核细胞诱导的K562细胞、UT-7细胞和CD61前巨核细胞中使用小干扰RNA(siRNA)敲低p19会导致S期进展和多倍体增加,以及巨核细胞分化改善,这与miR-125b过表达的效果相似。如巨核细胞标志物表达降低、G1期停滞和多倍体减少所示,p19的过表达可逆转这些效应。在miR-125b下调的细胞中敲低p19或在miR-125b上调的细胞中过表达p19可挽救miR-125b的效应。综上所述,这些发现表明,自巨核细胞确定的初始阶段起,miR-125b的表达正向调节巨核细胞发育,并且p19是巨核细胞多倍体化开始时miR-125b活性的关键介质之一。

相似文献

1
miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19.
Cell Death Dis. 2016 Oct 20;7(10):e2430. doi: 10.1038/cddis.2016.288.
2
miRNAs can increase the efficiency of ex vivo platelet generation.
Ann Hematol. 2012 Nov;91(11):1673-84. doi: 10.1007/s00277-012-1517-z. Epub 2012 Jul 5.
3
p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging.
Stem Cell Reports. 2014 Dec 9;3(6):1085-102. doi: 10.1016/j.stemcr.2014.10.005. Epub 2014 Nov 20.
4
P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1.
Blood. 2008 Apr 15;111(8):4081-91. doi: 10.1182/blood-2007-09-113266. Epub 2008 Feb 14.
6
MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
Cell Death Differ. 2015 Dec;22(12):1906-21. doi: 10.1038/cdd.2015.30. Epub 2015 Apr 10.
7
miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
Blood. 2009 Sep 3;114(10):2181-92. doi: 10.1182/blood-2009-02-205062. Epub 2009 Jul 7.
8
Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.
Hematology. 2013 Mar;18(2):93-100. doi: 10.1179/1607845412Y.0000000047. Epub 2012 Nov 19.
9
PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
Exp Hematol. 2012 Dec;40(12):1028-1042.e3. doi: 10.1016/j.exphem.2012.08.004. Epub 2012 Aug 22.

引用本文的文献

3
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4.
Thromb J. 2024 Aug 9;22(1):74. doi: 10.1186/s12959-024-00615-6.
4
The accumulation of miR-125b-5p is indispensable for efficient erythroblast enucleation.
Cell Death Dis. 2022 Oct 21;13(10):886. doi: 10.1038/s41419-022-05331-5.
5
Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation.
Cardiol J. 2024;31(1):111-123. doi: 10.5603/CJ.a2022.0090. Epub 2022 Oct 6.
7
Megakaryocyte ontogeny: Clinical and molecular significance.
Exp Hematol. 2018 May;61:1-9. doi: 10.1016/j.exphem.2018.02.003. Epub 2018 Mar 2.

本文引用的文献

1
Diverse functions of miR-125 family in different cell contexts.
J Hematol Oncol. 2013 Jan 15;6:6. doi: 10.1186/1756-8722-6-6.
2
miRNAs can increase the efficiency of ex vivo platelet generation.
Ann Hematol. 2012 Nov;91(11):1673-84. doi: 10.1007/s00277-012-1517-z. Epub 2012 Jul 5.
3
MicroRNAs in platelet production and activation.
Blood. 2011 May 19;117(20):5289-96. doi: 10.1182/blood-2011-01-292011. Epub 2011 Mar 1.
5
MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets.
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21505-10. doi: 10.1073/pnas.1016218107. Epub 2010 Nov 30.
6
MicroRNAs: emerging key regulators of hematopoiesis.
Am J Hematol. 2010 Dec;85(12):935-42. doi: 10.1002/ajh.21863.
7
MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output.
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14235-40. doi: 10.1073/pnas.1009798107. Epub 2010 Jul 26.
8
Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process.
Blood. 2010 Sep 30;116(13):2345-55. doi: 10.1182/blood-2010-01-265785. Epub 2010 Jun 14.
9
New roles for cyclin E in megakaryocytic polyploidization.
J Biol Chem. 2010 Jun 11;285(24):18909-17. doi: 10.1074/jbc.M110.102145. Epub 2010 Apr 14.
10
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Genes Dev. 2010 Mar 1;24(5):478-90. doi: 10.1101/gad.1856210.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验